Nightingale Health

How often to retest blood biomarkers depends on which biomarker, your age, health status, medications, and whether results are normal or changed by treatment or lifestyle. Below are practical, commonly used intervals and reasons, plus recommended lab services you can use. General principles Get a baseline panel once (if you don’t already have one). That helps interpret future change. Retest sooner after a treatment or major lifestyle change (medication start/change, new supplement, large weight loss, new diagnosis). If results are abnormal or you’re high-risk, test more frequently; if stable and low-risk, test less often. Always discuss frequency and interpretation with your clinician before acting. Suggested intervals for common tests Comprehensive metabolic panel (CMP: liver, kidney, electrolytes): baseline, then every 6–12 months if stable; 2–6 weeks after starting or changing meds that affect liver/kidney. Lipid panel (cholesterol, LDL, HDL, triglycerides): baseline, 4–12 weeks after starting/changing statin or major diet change, then every 6–12 months until stable, otherwise every 1–4 years for low-risk adults depending on age and guidelines. Hemoglobin A1c: every 3 months if diabetic or changing diabetes meds; every 6 months if prediabetic or not at goal; annually if stable and low risk. Fasting glucose/insulin: baseline, 3 months after major weight change or med change; frequency similar to A1c. Complete blood count (CBC): baseline, then every 6–12 months if stable; sooner (2–8 weeks) if treating anemia or a hematologic condition. Thyroid tests (TSH ± free T4): 6–8 weeks after starting or changing thyroid meds, then every 6–12 months if stable. High-sensitivity CRP (inflammation): baseline, 4–12 weeks after intervention (weight loss, smoking cessation, meds) to assess change; not useful as a daily measure. Ferritin/iron studies: 8–12 weeks after starting iron repletion; baseline and then PRN for monitoring. Vitamin D (25-OH): baseline, then 8–12 weeks after starting supplementation to confirm repletion, thereafter 6–12 months if supplementing. Testosterone (men) / estradiol (women) and reproductive hormones: baseline; 6–12 weeks after therapy changes, then every 6–12 months. PSA (men): follow clinician guidance; often discussed around ages 55–69 and then individualized — commonly checked annually or every 2–4 years depending on risk. Advanced or specialized panels (genetic risk, proteomics, metabolomics): baseline and then only as directed by specialist — these are not generally repeated frequently. Timing/fasting notes Fasting (8–12 hours) for glucose and sometimes lipid testing (although many clinics accept non-fasting lipids). Draw morning samples for hormones like cortisol and testosterone for more consistent results. Where to get tests (brands/services) Quest Diagnostics or LabCorp — widely available clinical labs accepted by doctors and insurance; good for comprehensive, physician-ordered testing. Everlywell or LetsGetChecked — convenient at-home kits for common panels (cholesterol, A1c, thyroid), good for screening and convenience but review results with a clinician. InsideTracker or WellnessFX — consumer-focused panels with lifestyle-oriented interpretation and repeat testing programs; good if you want performance/optimization guidance. Thorne/Viome — sell targeted or integrative wellness tests (vitamin D, hormones, microbiome—Viome for microbiome); useful for supplement monitoring but interpret carefully. SomaLogic or Nightingale Health — advanced proteomics/metabolomics for research or high-end personalized profiling (expensive; not routine). Additional tips After a medication change or starting a supplement, plan a check at the interval listed above (e.g., 6–8 weeks for thyroid, 8–12 weeks for vitamin D). Keep a record of testing dates and results so trends are visible. If you use a direct-to-consumer lab kit, consider having abnormal or borderline results repeated at a clinical lab (Quest/LabCorp) and reviewed by your clinician. Discuss frequency with your primary care provider — they’ll tailor it to your risk profile and insurance considerations. If you tell me which specific biomarkers you’re tracking, your age and health conditions (or medications), I can give a tailored retesting schedule and suggest the best service for those tests.

Mentioned in position 10 of 10

Short answer: focus first on markers of cardiovascular health, metabolic (glucose/insulin) control, systemic inflammation, kidney/liver function, key hormones and micronutrients, and (optionally) advanced aging assays (NMR metabolomics, ApoB/LDL‑particle, epigenetic clocks). Those categories predict most of the disease burden that shortens lifespan and are actionable. What matters (prioritized) Lipids and atherogenic particle burden Tests: LDL‑C, HDL, triglycerides, ApoB, LDL‑particle number (LDL‑P) or NMR LipoProfile, Lp(a) Why: cardiovascular disease is the biggest driver of mortality; ApoB and LDL‑P often predict risk better than LDL‑C alone. Lp(a) is an independent genetic risk factor. Rough targets: LDL‑C <100 mg/dL for general prevention; <70 mg/dL if high risk. ApoB <80 mg/dL desirable. Lp(a) <50 mg/dL (or <125 nmol/L). Glycemic control / insulin resistance Tests: fasting glucose, fasting insulin, HbA1c, HOMA‑IR (from glucose + insulin) Why: diabetes and insulin resistance accelerate vascular disease, cancer risk, and functional decline. Targets: fasting glucose <100 mg/dL, HbA1c <5.7% (optimal individualized — lower within normal range is better without hypoglycemia). Keep fasting insulin low (many aim <8–10 μU/mL). Systemic inflammation Tests: hs‑CRP, optionally IL‑6 or GlycA (NMR) Why: chronic low‑grade inflammation predicts frailty, CVD, dementia and mortality. Targets: hs‑CRP <1 mg/L best; 1–3 mg/L moderate; >3 high. Kidney and liver function Tests: serum creatinine + eGFR, cystatin C (optional), urine albumin:creatinine ratio; ALT/AST, GGT, bilirubin Why: kidney/liver dysfunction shorten healthy lifespan and influence medication choice. Targets: eGFR >60 (ideally >90), ACR <30 mg/g, low/normal transaminases. Hematology and iron Tests: CBC (hemoglobin, hematocrit, RDW), ferritin, transferrin saturation Why: anemia and high RDW predict morbidity; iron overload (high ferritin/transferrin sat) links to worse outcomes in some studies. Targets: hemoglobin in normal range; avoid very high ferritin (context dependent). Hormones relevant to aging and function Tests: total/free testosterone (men), estradiol (women, as indicated), SHBG, IGF‑1 (contextual) Why: maintain muscle, bone, function; extremes (too low or too high) have risks. Targets: keep in normal, age‑appropriate ranges and treat symptoms, not numbers alone. Micronutrients and lifestyle biomarkers Tests: 25‑OH vitamin D, B12, folate, magnesium (if indicated), Omega‑3 index Why: deficiencies impair health; higher omega‑3 index associates with lower mortality. Targets: vitamin D 25‑OH ~30–50 ng/mL; omega‑3 index >8% optimal. Markers of cardiac stress Tests: NT‑proBNP (useful if cardiac disease suspected) Why: predicts heart failure and mortality. Optional/advanced tests (good if you want deeper risk profiling) NMR metabolomics (GlycA, lipoprotein particle sizes) — Nightingale Health or LabCorp NMR LipoProfile. ApoB/LDL‑P (if available) — LabCorp/Quest offer or NMR. Epigenetic clocks / DNA methylation biological age — TruDiagnostic is a major provider; gives a “biological age” estimate (useful for tracking interventions but still emerging). Telomere length tests and some specialty nutrient panels (SpectraCell) — interpret cautiously; not yet definitive for actionable clinical decisions. Practical testing sources and why LabCorp and Quest Diagnostics — wide test menus, physician‑ordered, include ApoB, advanced lipid panels, and routine labs. InsideTracker (or WellnessFX / WellnessFX merged offerings) — good if you want interpretation + personalized lifestyle recommendations based on labs; can order labs through them or upload LabCorp/Quest results. OmegaQuant — clinically validated Omega‑3 Index testing. TruDiagnostic — one of the more established epigenetic clock (DNA methylation age) services if you want a molecular aging metric. Nightingale Health (Europe) / LabCorp NMR LipoProfile — for NMR metabolomics and GlycA (inflammation + lipoprotein particle details). Everlywell / LetsGetChecked — direct‑to‑consumer home kits for some basic tests (convenient but limited panels; follow up with clinician for interpretation). What to do with the results (brief) If lipids are high → lifestyle first (diet, exercise, weight loss, smoking cessation); statin therapy under physician guidance if still elevated or high calculated risk. If glucose/insulin elevated → weight loss, carb quality control, regular exercise; consider metformin for prediabetes only with clinician discussion. If hs‑CRP elevated → search for causes (obesity, infections, periodontitis), improve sleep/activity/diet; consider anti‑inflammatory strategies under guidance. Correct vitamin D / B12 deficiency, raise omega‑3 index with fatty fish or fish oil if low. Manage high ferritin/transferrin saturation (evaluate for hemochromatosis; phlebotomy if indicated). Testing cadence Baseline full panel annually for most healthy adults; more often (every 3–6 months) if you’re changing meds, treating abnormal results, or using aggressive interventions. Advanced/epigenetic tests: every 6–12 months if used to track interventions (they can be more expensive). Caveats Individualization matters: targets depend on age, sex, clinical history and personal risk. For example, very low LDL in very old people may not always be appropriate without context. Some advanced biomarkers (telomere length, epigenetic clocks) are informative but still emerging — don’t base major medical decisions on them alone. Genetic markers (e.g., Lp(a)) are largely nonmodifiable; they change how aggressively you manage modifiable risks. If you want, tell me: your age, sex, major medical history, and whether you’re already on meds (statin, metformin, etc.), and I’ll give a focused list of the highest‑priority labs for you and target ranges to aim for.

Mentioned in position 1 of 10

Short answer: there’s no single “longevity” blood test. But several routinely measured biomarkers are strongly tied to long-term mortality and age-related disease risk — and they’re actionable. Below I list the highest‑value markers, what they indicate, rough “good” targets used in longevity medicine, how often to check them, and a few reputable labs/services you can use. Highest‑value biomarkers (why they matter and practical targets) Lipids / atherosclerosis risk LDL‑cholesterol (and non‑HDL): main driver of atherosclerotic cardiovascular disease. Lower is usually better for longevity. Practical targets: LDL <100 mg/dL for most people; <70 mg/dL if high risk. Non‑HDL <130 mg/dL. Apolipoprotein B (ApoB): better predictor than LDL mass for particle number. ApoB <80 mg/dL is commonly used as a target. Lipoprotein(a) [Lp(a)]: genetically determined risk factor — high Lp(a) markedly raises CVD risk; measured once to know baseline. Glycemia / metabolic health HbA1c: long‑term glucose control. Higher levels predict diabetes and vascular disease. Aim <5.7% for normal; many longevity clinicians prefer <5.5% if safe. Fasting glucose, fasting insulin, HOMA‑IR: help catch insulin resistance earlier than A1c. Inflammation & immune activation High‑sensitivity CRP (hs‑CRP): a robust predictor of cardiovascular events and mortality. Desirable <1 mg/L; 1–3 moderate; >3 high. (Research/optional) IL‑6 and TNFα are informative but less available clinically. Kidney & filtration markers Serum creatinine / eGFR: chronic kidney disease increases mortality risk. Cystatin C: more sensitive eGFR marker in some people and useful for combined eGFR equations. Urine albumin/creatinine ratio: early kidney damage predictor. Liver health / metabolic stress ALT, AST, GGT: elevated GGT especially correlates with metabolic disease and mortality risk. Hematology & frailty signals Complete blood count (CBC), especially hemoglobin and RDW (red cell distribution width). High RDW consistently predicts higher mortality and frailty. Cardiac stress NT‑proBNP or BNP: sensitive for occult heart strain/failure and predictive of outcomes even at “low” elevations. Nutrition / modifiable deficiencies 25‑hydroxy vitamin D (target commonly 30–50 ng/mL), B12, ferritin (iron stores) — extremes relate to poor outcomes. Thyroid TSH (with free T4/free T3 as needed): both low and high thyroid function affect aging/metabolism. Coagulation markers (in some situations) D‑dimer, fibrinogen: higher levels associate with clotting risk and mortality in older adults. Advanced/optional markers for a deeper view ApoB particle count, advanced lipoprotein testing. Lp‑PLA2, lipoprotein subfractions. Telomere length and epigenetic clocks (DNAm GrimAge, Horvath clocks): give a biological‑aging estimate (research/interpretive, not diagnostic). Proteomics/metabolomics (e.g., SomaLogic, Nightingale) can predict risk decades ahead but are mainly for research/precision programs. Which tests and services to use (reputable options) Clinical labs (standard, clinician‑grade) Quest Diagnostics and Labcorp — broad menu (lipids, ApoB, hs‑CRP, HbA1c, cystatin C, NT‑proBNP, vitamins). Your local hospital/academic center for specialty tests and nephrology/cardiology follow‑up. Consumer/precision wellness services (good for integrated interpretation) InsideTracker — aggregates labs, gives personalized targets and lifestyle interventions. Thorne WellConnect — at‑home sample kits tied to practitioners and actionable plans. Everlywell / LetsGetChecked — convenient at‑home collection for core panels, but verify what’s included. Advanced aging / research‑grade tests TruDiagnostic (epigenetic clocks), Life Length / TeloYears (telomere length), and SomaLogic or Nightingale Health for proteomics/metabolomics. How often to test Baseline: get a comprehensive baseline (CBC, CMP, lipid panel + ApoB/Lp(a), hs‑CRP, HbA1c, fasting glucose+insulin, vitamin D, TSH, urine albumin). Routine: annually for most healthy adults; every 3–6 months if you’re changing therapy (statins, weight loss, glucose management) or if abnormalities exist. Advanced tests (epigenetic/proteomic): once yearly or as recommended by the testing service — they’re best used to track trends over time. What to do with abnormal results Most of these markers are modifiable: diet (Mediterranean/plant‑forward), exercise (aerobic + resistance), sleep, smoking cessation, weight loss, and blood‑pressure control lower risk across markers. Medications (e.g., statins, antihypertensives, metformin) can be highly effective where appropriate — discuss with a clinician. Recheck after lifestyle changes or treatment adjustments to confirm improvement. Caveats Biomarkers are risk indicators, not guarantees. They must be interpreted in context (age, sex, family history, medications). Some advanced tests are still research-focused and add cost without clear, evidence‑based interventions. Always review results with a qualified clinician before starting or stopping medications. If you want, I can: Suggest a single “starter” lab panel you can order now (exact test names and typical targets), or Recommend which advanced test(s) make sense given your age, family history, and current health.

Mentioned in position 11 of 11

Short answer: it depends a lot — expect anywhere from about $50 for a few routine labs up to $1,000–5,000+ for very large proteomic/metabolomic research panels. Most “full” consumer wellness panels fall in the $150–600 range. Key factors that change cost Which biomarkers (basic chemistry, CBC, lipids, hormones, micronutrients, inflammatory markers, microbiome, proteomics/metabolomics, genetics). Who orders/does the test (doctor + insurance, direct-to-consumer lab, or specialty functional/proteomic company). Sample type (blood draw vs at‑home fingerstick/saliva/stool). Geography and lab pricing. Example price ranges and providers (names and why) Basic clinical set (CBC + CMP + lipid panel + A1c): $50–$300 if paying out of pocket. Major labs: Quest Diagnostics or LabCorp — widely available, tests ordered by a clinician or sometimes via employer/telehealth. Good if you want standard clinical results that many doctors will accept. Expanded wellness panels (add hormones, vitamin D, thyroid, inflammation markers): $150–$600. Direct‑to‑consumer options: InsideTracker, WellnessFX, Everlywell, LetsGetChecked — convenient, with interpretation and lifestyle guidance. Functional medicine / specialty panels (micronutrient testing, comprehensive hormone panels, advanced GI/stool tests): $200–$1,200. Providers: Genova Diagnostics, Vibrant Wellness — used by integrative clinicians; cover many niche markers not on routine labs. Advanced metabolomics / proteomics (research-grade panels, hundreds–thousands of biomarkers): $1,000–$5,000+ per sample. Providers: SomaLogic, Olink, Nightingale Health — used in research and specialized clinical programs; expensive but very high dimensional. Genetic testing (SNP panels / nutrigenomics): $100–$400 (23andMe, Ancestry, some clinical genetic labs), though interpretive services can add cost. Practical tips If you have health insurance, ask your clinician to order the tests — many routine panels are covered when medically indicated (your out‑of‑pocket cost will be lower). For general wellness tracking, DTC companies (InsideTracker, Everlywell, LetsGetChecked) balance price, convenience, and interpretation. For very comprehensive functional or proteomic testing, expect higher costs and plan to review results with an informed clinician. Shop around: LabCorp and Quest publish many prices, and DTC sites list package prices. Telehealth services often bundle physician ordering with lab draws. If you tell me which biomarkers you want measured (e.g., hormones, vitamins, inflammation, gut microbiome) and whether you’ll use insurance or want at‑home testing, I can recommend 2–3 specific panels and give approximate costs.

Mentioned in position 11 of 13

Short answer: the blood markers that most consistently predict long-term health and mortality are those that capture cardiometabolic risk, systemic inflammation, kidney/liver function, anemia/hematologic health, nutritional status, and (increasingly) cardiac biomarkers and advanced “omics” clocks. Below is a prioritized list, why each matters for longevity, what to watch for, and practical places to get them tested. Top priority markers (strongest evidence for predicting mortality/longevity) Lipids and lipoproteins Tests: standard lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides) plus ApoB and/or LDL particle number (LDL‑P) and Lp(a) when possible. Why: atherosclerotic cardiovascular disease is the leading cause of death; ApoB/LDL‑P and Lp(a) are better single predictors of atherogenic particle burden than LDL‑C alone. Practical targets (general): lower ApoB and LDL‑P are better; Lp(a) ideally <30–50 mg/dL. Discuss risk thresholds with clinician. Glycemic control / insulin resistance Tests: HbA1c, fasting glucose, fasting insulin (or HOMA-IR); consider an oral glucose tolerance test or continuous glucose monitoring (CGM) if concerned about variability. Why: chronically elevated glucose/insulin resistance predicts diabetes, cardiovascular disease, and lower lifespan. Target: HbA1c <5.7% (non-diabetic); aim for fasting glucose in normal range and low fasting insulin. Systemic inflammation Tests: high-sensitivity C‑reactive protein (hs‑CRP); IL‑6 or fibrinogen are useful if available. Why: chronic low-grade inflammation accelerates many aging processes and predicts mortality. Practical: hs‑CRP <1 mg/L is low risk; 1–3 moderate; >3 mg/L higher risk. Kidney function Tests: serum creatinine + eGFR, cystatin C (if possible), urine albumin-to-creatinine ratio (ACR). Why: reduced kidney function and albuminuria strongly predict cardiovascular events and mortality. Cardiac biomarkers (especially in middle-aged/older adults) Tests: NT-proBNP and high-sensitivity troponin (hs‑Tn). Why: detect subclinical heart strain and predict future heart failure and death earlier than symptoms. Hematology / cellular health Tests: CBC with differential; pay attention to hemoglobin, hematocrit, and red cell distribution width (RDW). Why: anemia and elevated RDW are reproducible predictors of mortality across ages. Liver health Tests: ALT, AST, GGT, alkaline phosphatase, albumin. Consider nonalcoholic fatty liver disease risk if elevated (Fibrosis scores or imaging). Why: liver dysfunction and fatty liver disease are tied to metabolic syndrome and higher mortality. Micronutrients and metabolic markers Tests: 25‑OH vitamin D, B12, folate, ferritin (and transferrin saturation/iron if concerned), homocysteine. Why: deficiencies or iron overload increase disease risk and impair healthspan. Omega‑3 index Tests: RBC omega‑3 index (EPA+DHA). Why: higher omega‑3 index (commonly >8%) is associated with lower cardiac death risk. Emerging / research-grade but increasingly used ApoA1/ApoB ratio, advanced metabolomics or proteomics (e.g., Nightingale, Olink, SomaScan), NMR LipoProfile (for LDL‑P), and DNA methylation (epigenetic) clocks (e.g., Horvath/PhenoAge via TruDiagnostic). Why: offer refined risk estimates or biological-aging readouts, but interpret cautiously and with clinical context. How to prioritize testing and frequency Baseline for most adults: annual to every 2–3 years for the core panels (lipids, glucose/HbA1c, hs‑CRP, CBC, CMP for liver/kidney, vitamin D). If abnormal or higher risk, test more often. Cardiac biomarkers (NT‑proBNP/hs‑Tn) and Lp(a) can be useful once as a baseline in middle-aged/older adults or those with family history. Use trends over time — trajectories matter more than a single isolated value. Where to get tests and services (specific names) Standard clinical labs: Quest Diagnostics and LabCorp — broad test menus, widely accepted by clinicians and insurance. Direct-to-consumer / home kits: Everlywell, LetsGetChecked, HealthLabs — convenient for basic panels (verify which tests they offer). Longevity-focused services with interpretation and action plans: InsideTracker — integrates blood biomarkers, genetics, gives actionable lifestyle recommendations and target ranges. TruDiagnostic — DNA methylation/epigenetic clocks, useful if you want biological-age measures (research/interpretive). OmegaQuant — for omega‑3 index testing. Nightingale Health (or similar metabolomics providers) and SomaLogic/Olink (proteomics) for advanced profiling if you want deep phenotyping (usually expensive/research-focused). For advanced lipid particle testing: LabCorp’s NMR LipoProfile or Quest offers options via specialty labs. Practical points and caveats The most impactful things for improving these markers (and longevity) are proven: stop smoking, maintain healthy weight, regular aerobic + resistance exercise, Mediterranean-type diet, control blood pressure and lipids, treat diabetes and metabolic syndrome, adequate sleep and stress management. Single tests are less useful than repeat measurements and clinical context (age, family history, medications). Always review abnormal results with a clinician before acting. Some advanced tests (epigenetic clocks, metabolomics) are informative but still evolving for clinical decision-making — use them to guide lifestyle rather than as definitive medical diagnoses. If you have a family history of early heart disease or unusual lab abnormalities, see a preventive cardiologist or a clinician who focuses on metabolic/aging medicine. If you’d like, tell me your age, sex, medical history and any recent lab results you have and I can prioritize which markers matter most for you and suggest tests and target ranges to discuss with your clinician.

Mentioned in position 9 of 11

Short answer: for predicting and improving healthy lifespan, focus first on cardiometabolic, inflammatory, kidney/liver, and metabolic-aging biomarkers — because they are the strongest, actionable predictors of morbidity and mortality. Below I list the highest-priority blood tests, why they matter, and where you can get them. High‑priority biomarkers (what to test and why) Lipids / atherosclerosis risk LDL‑C, non‑HDL, triglycerides — routine measures of heart disease risk. ApoB and/or LDL‑particle number (LDL‑P) — better measures of atherogenic particle burden than LDL‑C alone. Lipoprotein(a) [Lp(a)] — largely genetic, major independent risk factor; crucial to know if high. Where to get them: request a lipid panel + ApoB and Lp(a) from LabCorp or Quest; NMR lipoprofile (LDL‑P) is available via LabCorp (Vantera NMR) or specialty services such as Nightingale or some cardiometabolic clinics. Glucose metabolism and insulin resistance HbA1c, fasting glucose, fasting insulin (or HOMA‑IR) — predict diabetes and cardiovascular risk. Keeping HbA1c in the low-normal range is associated with longer healthspan. Where: standard panel at Quest or LabCorp; fasting insulin sometimes needs special order. Inflammation High‑sensitivity CRP (hs‑CRP) — simple inflammatory predictor of cardiovascular and overall mortality. Interleukin‑6 (IL‑6) and GlycA (if available) — stronger predictors in research settings, but less commonly ordered. Where: hs‑CRP available at Quest/LabCorp; GlycA via Nightingale; IL‑6 via specialty labs or research panels. Kidney and liver health Creatinine/eGFR and cystatin C (if available) — kidney function is strongly tied to outcomes. ALT/AST and GGT — liver health and metabolic dysfunction markers. Where: routine metabolic/comprehensive metabolic panel at Quest or LabCorp; cystatin C by special request. Hematology and general health CBC (hemoglobin, hematocrit, WBC) and albumin — anemia, immune status and low albumin are risk markers. Where: CBC and CMP at LabCorp/Quest. Hormones (age/gender dependent) Testosterone (total and free) in men; estradiol in women; DHEA-S; TSH/free T4 (thyroid). Why: low or imbalanced sex hormones and thyroid dysfunction affect muscle, bone, cognition and survival. Where: standard hormone panels at major labs; may need time-of-day ordering for testosterone. Micronutrients & metabolic risk modifiers 25‑OH vitamin D, vitamin B12, folate, and homocysteine — deficiencies or high homocysteine are linked to adverse outcomes. Where: Quest/LabCorp; micronutrient panels via SpectraCell (specialty micronutrient testing) or Direct­-to‑consumer kits. Advanced / research markers (optional) Epigenetic “biological age” (DNA methylation clocks) — gives an estimate of biological age and response to interventions. Where: TruDiagnostic is a leading commercial provider; Elysium offered related products; these are research‑focused but increasingly practical. Telomere length — widely available but limited predictive value compared with methylation clocks. Providers: TeloYears (older product), other specialty labs. NMR metabolomics (detailed lipoprotein subfractions, GlycA) — Nightingale Health and LabCorp NMR services provide high‑resolution risk info. Where to get tests and interpretation (brands/services to consider) LabCorp and Quest Diagnostics — large national labs. Reliable, accept physician orders; good for comprehensive metabolic panel, lipid panel, HbA1c, hs‑CRP, thyroid, hormones, Lp(a), and specialty tests like cystatin C or NMR lipoprofile. InsideTracker and WellnessFX — consumer-facing services that combine lab testing with personalized interpretation and lifestyle recommendations. Good if you want actionable guidance rather than raw numbers. Everlywell and LetsGetChecked — convenient at‑home kits for common tests (lipids, HbA1c, vitamin D, hormones). Useful for convenience but may not offer all specialty tests. TruDiagnostic — leading commercial epigenetic clock testing if you want DNA methylation biological‑age measures. Nightingale Health / LabCorp NMR (Vantera) — for advanced lipoprotein and metabolomics (GlycA and LDL‑P). SpectraCell — specialty micronutrient testing and intracellular nutrient panels (useful for complex deficiency workups). How to prioritize and act If you can only do a few tests: get a basic metabolic panel (CMP), lipid panel + ApoB or LDL‑P, HbA1c, hs‑CRP, CBC, and 25‑OH vitamin D. Add Lp(a) once. Frequency: every 6–12 months for stable patients; more often if you’re making big lifestyle, medication, or supplement changes. Interpret results with a clinician — many markers are actionable (statins for high ApoB/LDL‑P, PCSK9 or niacin consideration for very high Lp(a) in context, lifestyle/medication for glucose control, vitamin D/B12 repletion, etc.). Don’t chase single numbers only — trends over time and multimarker risk (lipids + inflammation + glucose + kidney function) are what predict longevity. Caveats Some tests (epigenetic age, telomere length, certain cytokines) are still research‑oriented and not yet proven to be clinical game‑changers. Use them to inform, not dictate, care. Genetic testing (APOE, LPA genetics) can add context but requires counseling for interpretation. If you want, tell me: your age, sex, major health conditions, and whether you want at‑home vs physician‑ordered testing — I’ll give a tailored, prioritized test panel and recommended providers.

Mentioned in position 3 of 11